Welcome, you are not signed in yet.
Log in? New User, Register?
Registration is FREE and offers great benefits
Today is: Tue, Sep 7, 2010 | 20:21 EDT
Add our site to your favorites
Your default homepage
Home
>>
Tech Directory
>>
NeuroMedix Inc.
Business Description
NeuroMedix Inc. (TSX-V: NMX) is a biotechnology and pharmaceutical company focused on the prevention and treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis through the development of therapeutic agents.
NeuroMedix's therapeutic candidates are based on research from a team of leading experts in the field of neuroinflammation from the Center for Drug Discovery and Chemical Biology at Northwestern University.
Tech Directory
NeuroMedix Inc.
| Last Update 2007/4/3 20:31 |
Category
Life Sciences
Biotechnology
Tel Number (416) 673-8190
Fax Number (416) 971-7300
Biotechnology
| Headoffice | |
| 101 College Street, Suite 335, Toronto, Ontario M5G 1L7 |
NeuroMedix Inc. (TSX-V: NMX) is a biotechnology and pharmaceutical company focused on the prevention and treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis through the development of therapeutic agents.
NeuroMedix's therapeutic candidates are based on research from a team of leading experts in the field of neuroinflammation from the Center for Drug Discovery and Chemical Biology at Northwestern University.
Executives and Directors
Dr. Mark L. Pearson, Ph.D., CEO, formerly President & CEO of Protana Inc/MDS Proteomics
Catherine Auld, CA, CFO, formerly CFO of Transition Therapeutics Inc
Board of Directors
Mark Pearson
Santo Costa, Chairman, Counsel to Maupin Taylor, formerl President & COO and Vice-Chairman of Transnational Corp
Timothy McCunn, Partner, Borden Ladner Gervais LLP
Gerald McDole, Corporate Director, formerly President & CEO of AstraZeneca Canada Inc’s pharmaceutical operations
Gerald Slemko, President & CEO of Cuddy International Corporation and President and a major shareholder of Chelsey Corporation Ltd
Dr. Mark L. Pearson, Ph.D., CEO, formerly President & CEO of Protana Inc/MDS Proteomics
Catherine Auld, CA, CFO, formerly CFO of Transition Therapeutics Inc
Board of Directors
Mark Pearson
Santo Costa, Chairman, Counsel to Maupin Taylor, formerl President & COO and Vice-Chairman of Transnational Corp
Timothy McCunn, Partner, Borden Ladner Gervais LLP
Gerald McDole, Corporate Director, formerly President & CEO of AstraZeneca Canada Inc’s pharmaceutical operations
Gerald Slemko, President & CEO of Cuddy International Corporation and President and a major shareholder of Chelsey Corporation Ltd
Hits: 20
Rating: 0.00 (0 votes)
Print
Tell a Friend
The comments are owned by the poster. We aren't responsible for their content.
| Poster | Thread |
|---|